CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Peloso, MD
COUR Pharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liver Institute Pllc
Tucson, Arizona, United States
Neda EbrahimiRecruiting - Wake Research - Tucson
Tucson, Arizona, United States
David AlsterRecruiting - Rady Children'S Hospital San Diego
San Diego, California, United States
Carla Demeterco-BerggrenRecruiting - Diablo Clinical Research
Walnut Creek, California, United States
Mark ChristiansenRecruiting - Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, United States
Taylor TrioloRecruiting - University of Florida
Gainesville, Florida, United States
Timothy FosterRecruiting - Evolution Research Center
Hialeah, Florida, United States
Andrea Sosa-MeloRecruiting - Dy Professional Research Center
Miami, Florida, United States
Soroush AghighRecruiting - University of Miami
Miami, Florida, United States
David BaidalRecruiting - Recruiting
- Atlanta Diabetes Association
Atlanta, Georgia, United States
Carson WomackRecruiting - Emory University
Atlanta, Georgia, United States
Michael HughesRecruiting - Southern Illinois University School of Medicine
Springfield, Illinois, United States
Gabriel UwaifoRecruiting - Riley Hospital for Children- Indiana University
Indianapolis, Indiana, United States
Linda DeMeglioRecruiting - Barry J. Reiner, Md, Llc
Baltimore, Maryland, United States
Barry ReinerRecruiting - Joslin Diabetes Center
Boston, Massachusetts, United States
Jason GagliaRecruiting - Embassy Research Network
Bloomfield Township, Michigan, United States
George GrunbergerRecruiting - University of Minnesota
Minneapolis, Minnesota, United States
Antoinette MoranRecruiting - Children'S Mercy Hospital
Kansas City, Missouri, United States
Wayne MooreRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Janet McGillRecruiting - Ubmd Pediatrics - University of Buffalo
Buffalo, New York, United States
Lucy MastrandreaRecruiting - Mainstreet Health
Syosset, New York, United States
Alla KhalfinRecruiting - Duke University
Durham, North Carolina, United States
Jennifer GreenRecruiting - Recruiting
- Wake Research - Raleigh
Raleigh, North Carolina, United States
Khushbu ChandaranaRecruiting - Superior Clinical Research
Smithfield, North Carolina, United States
Clifford CurtisRecruiting - University Diabetes & Endocrine Consultants
Chattanooga, Tennessee, United States
David HuffmanRecruiting - Texas Diabetes & Endocrinology
Austin, Texas, United States
Jean ChenRecruiting - M3 Wake Research - Dallas
Dallas, Texas, United States
Carlos Arauz-PachecoRecruiting - Accurate Clinical Research, Inc
Humble, Texas, United States
Brian ChouRecruiting - Diabetes & Glandular Disease (dgd) Clinic, P.A.
San Antonio, Texas, United States
Mark KipnesRecruiting - Topline Clinical, Inc
Waxahachie, Texas, United States
Stephen MuellerRecruiting - University of Washington Diabetes Institute
Seattle, Washington, United States
Irl HirschRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 May 2025
- Primary completion
- 31 Dec 2026
- Completion
- 30 Jun 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 72
- Registry id
- NCT06783309
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.